SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-11-004440
Filing Date
2011-11-14
Accepted
2011-11-14 17:29:32
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT slxcf_10q.htm 10-Q 799121
2 CERTIFICATION slxcf_ex311.htm EX-31.1 15444
3 CERTIFICATION slxcf_ex312.htm EX-31.2 15564
4 CERTIFICATION slxcf_ex321.htm EX-32.1 6511
5 CERTIFICATION slxcf_ex322.htm EX-32.2 7015
  Complete submission text file 0001354488-11-004440.txt   2075449

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT slxcf-20110930.xml EX-101.INS 212511
7 XBRL TAXONOMY EXTENSION SCHEMA slxcf-20110930.xsd EX-101.SCH 12348
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE slxcf-20110930_cal.xml EX-101.CAL 31763
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE slxcf-20110930_def.xml EX-101.DEF 8297
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE slxcf-20110930_lab.xml EX-101.LAB 76877
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slxcf-20110930_pre.xml EX-101.PRE 60091
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 111204751
SIC: 2834 Pharmaceutical Preparations